• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


DXB Investor Presentation14/09/20 download Created with Sketch. 3.7MB
DXB Positive Top-Line Results in DKD Phase 2 Clinical StudyPRICE SENSITIVE14/09/20 download Created with Sketch. 307.24KB
DXB Trading HaltPRICE SENSITIVE10/09/20 download Created with Sketch. 363.42KB
DXB Dimerix Awarded $1 Million MRFF FundingPRICE SENSITIVE03/09/20 download Created with Sketch. 354.09KB
DXB Notice of Annual General Meeting/Proxy Form01/09/20 download Created with Sketch. 1.09MB
DXB Annual General Meeting - Notice and Letter to Shareholders01/09/20 download Created with Sketch. 818.23KB
DXB Appendix 4G and Corporate Governance Statement27/08/20 download Created with Sketch. 501.91KB
DXB Annual Report to shareholders27/08/20 download Created with Sketch. 3.18MB
DXB Preliminary Final ReportPRICE SENSITIVE27/08/20 download Created with Sketch. 126.66KB
DXB Investor Presentation29/07/20 download Created with Sketch. 3.45MB
DXB Positive Top-Line Results in FSGS Phase 2a Clinical StudyPRICE SENSITIVE29/07/20 download Created with Sketch. 279.06KB
DXB Trading HaltPRICE SENSITIVE27/07/20 download Created with Sketch. 364.82KB
DXB Last Patient Completes Dosing in DKD Phase 2 Clinical StudyPRICE SENSITIVE24/07/20 download Created with Sketch. 245.43KB
DXB Change in substantial holding20/07/20 download Created with Sketch. 444.93KB
DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE14/07/20 download Created with Sketch. 552.22KB
DXB DMX-700 Program for COPD Advances06/07/20 download Created with Sketch. 229.47KB
DXB Cleansing Notice29/06/20 download Created with Sketch. 353.87KB
DXB Appendix 2A29/06/20 download Created with Sketch. 287.2KB
DXB Proposed issue of Securities - DXB22/06/20 download Created with Sketch. 24.96KB
DXB Dimerix Completes $5.8m PlacementPRICE SENSITIVE22/06/20 download Created with Sketch. 258.28KB
DXB Trading HaltPRICE SENSITIVE18/06/20 download Created with Sketch. 553.4KB
DXB Last Patient Completes Dosing in FSGS Phase 2 Clinical StudyPRICE SENSITIVE17/06/20 download Created with Sketch. 261.83KB
DXB Investor Presentation04/06/20 download Created with Sketch. 3.58MB
DXB Global REMAP-CAP Platform Trial Protocol To Include DMX-200PRICE SENSITIVE04/06/20 download Created with Sketch. 287.37KB
DXB Trading HaltPRICE SENSITIVE02/06/20 download Created with Sketch. 363.65KB
DXB Dimerix to Present at NWR Virtual Health Conference01/05/20 download Created with Sketch. 2.49MB
DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE21/04/20 download Created with Sketch. 447.79KB
DXB R&D Tax Incentive FacilityPRICE SENSITIVE03/04/20 download Created with Sketch. 263.77KB
DXB Lapse of Options01/04/20 download Created with Sketch. 259.42KB
DXB Dimerix Clinical Studies Update18/03/20 download Created with Sketch. 515.9KB
DXB Investor Presentation09/03/20 download Created with Sketch. 3.86MB
DXB Dimerix Appoints New DMX-200 Medical Advisory Board06/03/20 download Created with Sketch. 236.41KB
DXB DMX-200 Treatment Continued Under TGA Special Access SchemePRICE SENSITIVE03/03/20 download Created with Sketch. 291.19KB
DXB Half Year Report and Update19/02/20 download Created with Sketch. 268.67KB
DXB Half Yearly Report and AccountsPRICE SENSITIVE19/02/20 download Created with Sketch. 1.19MB
DXB Quarterly Commentary & Appendix 4CPRICE SENSITIVE21/01/20 download Created with Sketch. 512.51KB
DXB Biotech Partnering Showcase Conference Presentation13/01/20 download Created with Sketch. 4.15MB
DXB Change in substantial holding10/01/20 download Created with Sketch. 49.69KB
DXB DMX-200 Clinical Trial UpdatePRICE SENSITIVE07/01/20 download Created with Sketch. 274.26KB
DXB Appendix 3B09/12/19 download Created with Sketch. 508.34KB
DXB Cleansing Notice09/12/19 download Created with Sketch. 353.83KB
DXB Dimerix Completes $2.5m PlacementPRICE SENSITIVE03/12/19 download Created with Sketch. 281.55KB
DXB Trading HaltPRICE SENSITIVE29/11/19 download Created with Sketch. 556.96KB
DXB Results of Meeting28/11/19 download Created with Sketch. 322.37KB
DXB AGM Presentation28/11/19 download Created with Sketch. 1.46MB
DXB CEO's Address to Shareholders28/11/19 download Created with Sketch. 599.69KB
DXB Dimerix Holds Pre-IND Meeting on DMX-200 With FDAPRICE SENSITIVE25/11/19 download Created with Sketch. 227.79KB
DXB Appendix 3B12/11/19 download Created with Sketch. 614.97KB
DXB Bio-Europe Conference Presentation11/11/19 download Created with Sketch. 3.87MB
DXB Ausbiotech Conference Presentation30/10/19 download Created with Sketch. 2.19MB
DXB Notice of Annual General Meeting/Proxy Form29/10/19 download Created with Sketch. 1.24MB
DXB Quarterly Commentary & Appendix 4CPRICE SENSITIVE25/10/19 download Created with Sketch. 565.91KB
DXB Dimerix Awarded Second Innovation Connections Grant23/10/19 download Created with Sketch. 201.82KB
DXB Final Director's Interest Notice11/10/19 download Created with Sketch. 252.26KB
DXB Director Resignation11/10/19 download Created with Sketch. 223.38KB
DXB New Drug Pipeline Candidate DMX-700 & Company UpdatePRICE SENSITIVE10/10/19 download Created with Sketch. 3.08MB
DXB Receipt of R&D Tax IncentivePRICE SENSITIVE08/10/19 download Created with Sketch. 225.43KB
DXB DMX-200 Phase 2 Clinical Study in DKD Completes RecruitmentPRICE SENSITIVE26/09/19 download Created with Sketch. 180.46KB
DXB Additional US Patent Covering DMX-20017/09/19 download Created with Sketch. 187.02KB
DXB Annual Report to shareholders29/08/19 download Created with Sketch. 3.42MB
DXB Appendix 4G and Corporate Governance Statement29/08/19 download Created with Sketch. 388.03KB
DXB Preliminary Final ReportPRICE SENSITIVE29/08/19 download Created with Sketch. 95.58KB
DXB Appendix 3B09/08/19 download Created with Sketch. 458.89KB
DXB Dimerix to Present at Bioshares Biotech Summit 201925/07/19 download Created with Sketch. 977.25KB
DXB Quarterly Commentary & Appendix 4CPRICE SENSITIVE16/07/19 download Created with Sketch. 350.91KB
DXB First DMX-200 Patents To Grant In Europe And Canada11/07/19 download Created with Sketch. 187.22KB
DXB DMX-200 Phase 2 Clinical Trial in FSGS Fully RecruitedPRICE SENSITIVE10/07/19 download Created with Sketch. 231.92KB
DXB Investor Presentation26/06/19 download Created with Sketch. 1.18MB
DXB DMX-200 Clinical UpdatePRICE SENSITIVE26/06/19 download Created with Sketch. 280.1KB
DXB Dimerix Signs Licence Agreement for Receptor-HIT TechnologyPRICE SENSITIVE24/06/19 download Created with Sketch. 195.39KB
DXB DMX-200 Manufacturing UpdatePRICE SENSITIVE27/05/19 download Created with Sketch. 256.75KB
DXB CFO and Company Secretary Appointment/Resignation06/05/19 download Created with Sketch. 400.89KB
DXB Appendix 4C - quarterlyPRICE SENSITIVE26/04/19 download Created with Sketch. 146.02KB
DXB Appendix 3B15/03/19 download Created with Sketch. 420.01KB
DXB Trial Update Presentation05/03/19 download Created with Sketch. 3.21MB
DXB Half Year Report & DMX-200 Clinical Trials Update26/02/19 download Created with Sketch. 192.06KB
DXB Half Yearly Report and AccountsPRICE SENSITIVE26/02/19 download Created with Sketch. 1.22MB
DXB Appendix 4C and Quarterly HighlightsPRICE SENSITIVE31/01/19 download Created with Sketch. 311.52KB
DXB Appendix 3B29/01/19 download Created with Sketch. 421.38KB
DXB Appendix 3B14/01/19 download Created with Sketch. 422.53KB
DXB Dimerix Receives R&D Tax Cash Rebate Totalling $1.07mPRICE SENSITIVE20/12/18 download Created with Sketch. 124.97KB
DXB Change of Director's Interest Notice27/11/18 download Created with Sketch. 203.71KB
DXB Appendix 3B27/11/18 download Created with Sketch. 431.66KB
DXB Dimerix Awarded $50,000 Innovation Connections Grant26/11/18 download Created with Sketch. 145.77KB
DXB 1st Patient Dosed in DMX-200 Clinical Trial for FSGSPRICE SENSITIVE22/11/18 download Created with Sketch. 133.95KB
DXB DXB Receives Orphan Drug Designation in EUPRICE SENSITIVE21/11/18 download Created with Sketch. 186.18KB
DXB FIRST PATIENT DOSED IN DMX-200 CLINICAL TRIALPRICE SENSITIVE19/11/18 download Created with Sketch. 132.96KB
DXB Change of Address12/11/18 download Created with Sketch. 117.14KB
DXB Results of Meeting30/10/18 download Created with Sketch. 141.49KB
DXB AGM Presentation and CEO Address30/10/18 download Created with Sketch. 1.61MB
DXB Appendix 4C - quarterlyPRICE SENSITIVE29/10/18 download Created with Sketch. 148.78KB
DXB AGM Dial-In Details25/10/18 download Created with Sketch. 73.92KB
DXB Investor Update15/10/18 download Created with Sketch. 1.72MB
DXB Appendix 3B24/09/18 download Created with Sketch. 443.6KB
DXB Notice of Annual General Meeting/Proxy Form21/09/18 download Created with Sketch. 754.2KB
DXB Change of Director's Interest Notice11/09/18 download Created with Sketch. 200.78KB
DXB Annual Report to shareholders30/08/18 download Created with Sketch. 1.12MB
DXB Appendix 4G and Corporate Governance Statement30/08/18 download Created with Sketch. 532.72KB
DXB Preliminary Final ReportPRICE SENSITIVE30/08/18 download Created with Sketch. 151.46KB
DXB Initial Director's Interest Notice28/08/18 download Created with Sketch. 145.64KB
DXB Investor Presentation
14/09/20 download Created with Sketch. 3.7MB
DXB Positive Top-Line Results in DKD Phase 2 Clinical Study
14/09/20PRICE SENSITIVE download Created with Sketch. 307.24KB
DXB Trading Halt
10/09/20PRICE SENSITIVE download Created with Sketch. 363.42KB
DXB Dimerix Awarded $1 Million MRFF Funding
03/09/20PRICE SENSITIVE download Created with Sketch. 354.09KB
DXB Notice of Annual General Meeting/Proxy Form
01/09/20 download Created with Sketch. 1.09MB
DXB Annual General Meeting - Notice and Letter to Shareholders
01/09/20 download Created with Sketch. 818.23KB
DXB Appendix 4G and Corporate Governance Statement
27/08/20 download Created with Sketch. 501.91KB
DXB Annual Report to shareholders
27/08/20 download Created with Sketch. 3.18MB
DXB Preliminary Final Report
27/08/20PRICE SENSITIVE download Created with Sketch. 126.66KB
DXB Investor Presentation
29/07/20 download Created with Sketch. 3.45MB
DXB Positive Top-Line Results in FSGS Phase 2a Clinical Study
29/07/20PRICE SENSITIVE download Created with Sketch. 279.06KB
DXB Trading Halt
27/07/20PRICE SENSITIVE download Created with Sketch. 364.82KB
DXB Last Patient Completes Dosing in DKD Phase 2 Clinical Study
24/07/20PRICE SENSITIVE download Created with Sketch. 245.43KB
DXB Change in substantial holding
20/07/20 download Created with Sketch. 444.93KB
DXB Quarterly Appendix 4C and Activities Report
14/07/20PRICE SENSITIVE download Created with Sketch. 552.22KB
DXB DMX-700 Program for COPD Advances
06/07/20 download Created with Sketch. 229.47KB
DXB Cleansing Notice
29/06/20 download Created with Sketch. 353.87KB
DXB Appendix 2A
29/06/20 download Created with Sketch. 287.2KB
DXB Proposed issue of Securities - DXB
22/06/20 download Created with Sketch. 24.96KB
DXB Dimerix Completes $5.8m Placement
22/06/20PRICE SENSITIVE download Created with Sketch. 258.28KB
DXB Trading Halt
18/06/20PRICE SENSITIVE download Created with Sketch. 553.4KB
DXB Last Patient Completes Dosing in FSGS Phase 2 Clinical Study
17/06/20PRICE SENSITIVE download Created with Sketch. 261.83KB
DXB Investor Presentation
04/06/20 download Created with Sketch. 3.58MB
DXB Global REMAP-CAP Platform Trial Protocol To Include DMX-200
04/06/20PRICE SENSITIVE download Created with Sketch. 287.37KB
DXB Trading Halt
02/06/20PRICE SENSITIVE download Created with Sketch. 363.65KB
DXB Dimerix to Present at NWR Virtual Health Conference
01/05/20 download Created with Sketch. 2.49MB
DXB Quarterly Appendix 4C and Activities Report
21/04/20PRICE SENSITIVE download Created with Sketch. 447.79KB
DXB R&D Tax Incentive Facility
03/04/20PRICE SENSITIVE download Created with Sketch. 263.77KB
DXB Lapse of Options
01/04/20 download Created with Sketch. 259.42KB
DXB Dimerix Clinical Studies Update
18/03/20 download Created with Sketch. 515.9KB
DXB Investor Presentation
09/03/20 download Created with Sketch. 3.86MB
DXB Dimerix Appoints New DMX-200 Medical Advisory Board
06/03/20 download Created with Sketch. 236.41KB
DXB DMX-200 Treatment Continued Under TGA Special Access Scheme
03/03/20PRICE SENSITIVE download Created with Sketch. 291.19KB
DXB Half Year Report and Update
19/02/20 download Created with Sketch. 268.67KB
DXB Half Yearly Report and Accounts
19/02/20PRICE SENSITIVE download Created with Sketch. 1.19MB
DXB Quarterly Commentary & Appendix 4C
21/01/20PRICE SENSITIVE download Created with Sketch. 512.51KB
DXB Biotech Partnering Showcase Conference Presentation
13/01/20 download Created with Sketch. 4.15MB
DXB Change in substantial holding
10/01/20 download Created with Sketch. 49.69KB
DXB DMX-200 Clinical Trial Update
07/01/20PRICE SENSITIVE download Created with Sketch. 274.26KB
DXB Appendix 3B
09/12/19 download Created with Sketch. 508.34KB
DXB Cleansing Notice
09/12/19 download Created with Sketch. 353.83KB
DXB Dimerix Completes $2.5m Placement
03/12/19PRICE SENSITIVE download Created with Sketch. 281.55KB
DXB Trading Halt
29/11/19PRICE SENSITIVE download Created with Sketch. 556.96KB
DXB Results of Meeting
28/11/19 download Created with Sketch. 322.37KB
DXB AGM Presentation
28/11/19 download Created with Sketch. 1.46MB
DXB CEO's Address to Shareholders
28/11/19 download Created with Sketch. 599.69KB
DXB Dimerix Holds Pre-IND Meeting on DMX-200 With FDA
25/11/19PRICE SENSITIVE download Created with Sketch. 227.79KB
DXB Appendix 3B
12/11/19 download Created with Sketch. 614.97KB
DXB Bio-Europe Conference Presentation
11/11/19 download Created with Sketch. 3.87MB
DXB Ausbiotech Conference Presentation
30/10/19 download Created with Sketch. 2.19MB
DXB Notice of Annual General Meeting/Proxy Form
29/10/19 download Created with Sketch. 1.24MB
DXB Quarterly Commentary & Appendix 4C
25/10/19PRICE SENSITIVE download Created with Sketch. 565.91KB
DXB Dimerix Awarded Second Innovation Connections Grant
23/10/19 download Created with Sketch. 201.82KB
DXB Final Director's Interest Notice
11/10/19 download Created with Sketch. 252.26KB
DXB Director Resignation
11/10/19 download Created with Sketch. 223.38KB
DXB New Drug Pipeline Candidate DMX-700 & Company Update
10/10/19PRICE SENSITIVE download Created with Sketch. 3.08MB
DXB Receipt of R&D Tax Incentive
08/10/19PRICE SENSITIVE download Created with Sketch. 225.43KB
DXB DMX-200 Phase 2 Clinical Study in DKD Completes Recruitment
26/09/19PRICE SENSITIVE download Created with Sketch. 180.46KB
DXB Additional US Patent Covering DMX-200
17/09/19 download Created with Sketch. 187.02KB
DXB Annual Report to shareholders
29/08/19 download Created with Sketch. 3.42MB
DXB Appendix 4G and Corporate Governance Statement
29/08/19 download Created with Sketch. 388.03KB
DXB Preliminary Final Report
29/08/19PRICE SENSITIVE download Created with Sketch. 95.58KB
DXB Appendix 3B
09/08/19 download Created with Sketch. 458.89KB
DXB Dimerix to Present at Bioshares Biotech Summit 2019
25/07/19 download Created with Sketch. 977.25KB
DXB Quarterly Commentary & Appendix 4C
16/07/19PRICE SENSITIVE download Created with Sketch. 350.91KB
DXB First DMX-200 Patents To Grant In Europe And Canada
11/07/19 download Created with Sketch. 187.22KB
DXB DMX-200 Phase 2 Clinical Trial in FSGS Fully Recruited
10/07/19PRICE SENSITIVE download Created with Sketch. 231.92KB
DXB Investor Presentation
26/06/19 download Created with Sketch. 1.18MB
DXB DMX-200 Clinical Update
26/06/19PRICE SENSITIVE download Created with Sketch. 280.1KB
DXB Dimerix Signs Licence Agreement for Receptor-HIT Technology
24/06/19PRICE SENSITIVE download Created with Sketch. 195.39KB
DXB DMX-200 Manufacturing Update
27/05/19PRICE SENSITIVE download Created with Sketch. 256.75KB
DXB CFO and Company Secretary Appointment/Resignation
06/05/19 download Created with Sketch. 400.89KB
DXB Appendix 4C - quarterly
26/04/19PRICE SENSITIVE download Created with Sketch. 146.02KB
DXB Appendix 3B
15/03/19 download Created with Sketch. 420.01KB
DXB Trial Update Presentation
05/03/19 download Created with Sketch. 3.21MB
DXB Half Year Report & DMX-200 Clinical Trials Update
26/02/19 download Created with Sketch. 192.06KB
DXB Half Yearly Report and Accounts
26/02/19PRICE SENSITIVE download Created with Sketch. 1.22MB
DXB Appendix 4C and Quarterly Highlights
31/01/19PRICE SENSITIVE download Created with Sketch. 311.52KB
DXB Appendix 3B
29/01/19 download Created with Sketch. 421.38KB
DXB Appendix 3B
14/01/19 download Created with Sketch. 422.53KB
DXB Dimerix Receives R&D Tax Cash Rebate Totalling $1.07m
20/12/18PRICE SENSITIVE download Created with Sketch. 124.97KB
DXB Change of Director's Interest Notice
27/11/18 download Created with Sketch. 203.71KB
DXB Appendix 3B
27/11/18 download Created with Sketch. 431.66KB
DXB Dimerix Awarded $50,000 Innovation Connections Grant
26/11/18 download Created with Sketch. 145.77KB
DXB 1st Patient Dosed in DMX-200 Clinical Trial for FSGS
22/11/18PRICE SENSITIVE download Created with Sketch. 133.95KB
DXB DXB Receives Orphan Drug Designation in EU
21/11/18PRICE SENSITIVE download Created with Sketch. 186.18KB
DXB FIRST PATIENT DOSED IN DMX-200 CLINICAL TRIAL
19/11/18PRICE SENSITIVE download Created with Sketch. 132.96KB
DXB Change of Address
12/11/18 download Created with Sketch. 117.14KB
DXB Results of Meeting
30/10/18 download Created with Sketch. 141.49KB
DXB AGM Presentation and CEO Address
30/10/18 download Created with Sketch. 1.61MB
DXB Appendix 4C - quarterly
29/10/18PRICE SENSITIVE download Created with Sketch. 148.78KB
DXB AGM Dial-In Details
25/10/18 download Created with Sketch. 73.92KB
DXB Investor Update
15/10/18 download Created with Sketch. 1.72MB
DXB Appendix 3B
24/09/18 download Created with Sketch. 443.6KB
DXB Notice of Annual General Meeting/Proxy Form
21/09/18 download Created with Sketch. 754.2KB
DXB Change of Director's Interest Notice
11/09/18 download Created with Sketch. 200.78KB
DXB Annual Report to shareholders
30/08/18 download Created with Sketch. 1.12MB
DXB Appendix 4G and Corporate Governance Statement
30/08/18 download Created with Sketch. 532.72KB
DXB Preliminary Final Report
30/08/18PRICE SENSITIVE download Created with Sketch. 151.46KB
DXB Initial Director's Interest Notice
28/08/18 download Created with Sketch. 145.64KB
(20min delay)
Last
24.5¢
Change
0.005(2.08%)
Mkt cap ! $48.44M
Open High Low Value Volume
25.0¢ 25.5¢ 24.5¢ $408.8K 1.644M

Buyers (Bids)

No. Vol. Price($)
12 293577 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 46967 5
View Market Depth
Last trade - 16.10pm 18/09/2020 (20 minute delay) ?
(live)
Last
24.5¢
  Change
0.005 ( 2.73 %)
Open High Low Volume
25.0¢ 25.5¢ 24.0¢ 1975399
Last updated 15.59pm 18/09/2020 (live) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.